Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses
Open Access
- 1 November 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 13 (11) , 1361-1365
- https://doi.org/10.1093/intimm/13.11.1361
Abstract
The metastatic potential of some tumor cells is associated with the expression of the neolactoseries antigens sialyl-Lewis x (sLex) and sialyl-Lewis a (sLea) as they are ligands for selectins. We have recently shown that peptide mimetics of these antigens can potentiate IgG2a antibodies, which are associated with a Th1-type cellular response. As L-selectin is preferentially expressed on CD4+ Th1 and CD8+ T cell populations, specific induction of these phenotypes could augment a response to L-selectin ligand-expressing tumor cells. Here we demonstrate that immunization with a multiple antigen peptide (MAP) mimetic of sugar constituents of neolactoseries antigens induces a MHC-dependent peptide-specific cellular response that triggers IFN-γ production upon peptide stimulation, correlating with IgG2a induction. Surprisingly, T lymphocytes from peptide-immunized animals were activated in vitro by sLex, also triggering IFN-γ production in a MHC-dependent manner. Stimulation by peptide or carbohydrate resulted in loss of L-selectin on CD4+ T cells confirming a Th1 phenotype. We also observed an enhancement in cytotoxic T lymphocyte (CTL) activity in vitroagainst sLex-expressing Meth A cells using effector cells from Meth A-primed/peptide-boosted animals. CTL activity was inhibited by both anti-MHC class I and anti-L-selectin antibodies. These results further support a role forL-selectin in tumor rejection along with the engagement by the TCR for most likely processedtumor-associated glycopeptides, focusing on peptide mimetics as a means to induce carbohydrate reactive cellular responses.Keywords
This publication has 54 references indexed in Scilit:
- Expression of Carbohydrate Antigens in Advanced-Stage Ovarian Carcinomas and Their Metastases—A Clinicopathologic StudyGynecologic Oncology, 2000
- Endothelial Ligands for L-Selectin: From Lymphocyte Recirculation to Allograft RejectionThe American Journal of Pathology, 1999
- Sequential T Cell Response Involved in Tumor Rejection of Sarcoma, Meth A, in Syngeneic MiceJapanese Journal of Cancer Research, 1998
- Superantigens but not mitogens are capable of inducing upregulation of E-selectin ligands on human T lymphocytesExperimental Dermatology, 1997
- Endothelial-selectin ligands sialyl Lewisx and sialyl Lewisa are differentiation antigens immunogenic in human melanomaCancer, 1997
- Cellular cancer vaccine induces delayed-type hypersensitivity reaction and augments antibody response to tumor-associated carbohydrate antigens (sialyl Lea, sialyl Lex, GD3 and GM2) better than soluble lysate cancer vaccineAnti-Cancer Drugs, 1997
- Subsets of sialylated, sulfated mucins of diverse origins are recognized by L-selectin. Lack of evidence for unique oligosaccharide sequences mediating bindingGlycobiology, 1996
- Peptide Binding and Presentation by Mouse CD1Science, 1995
- Expression of Lewis X-related antigens in adenocarcinomas of lungHistopathology, 1993
- Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancerCancer, 1993